| Ticker: | IMRN |
| Current Price: | $0.88 |
| % Daily Change: | -3.52% |
| Volume (1,000s): | 16.10 |
| Average Volume (1,000s): | 251.37 |
| Market Cap (M): | $5.64 |
| 1/2/2024 Price: | $1.90 |
| Change Since Inception: | -53.68% |
Immuron Limited
62 Lygon Street
Level 3
Carlton, VIC 3053
Australia
Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases.